1. Perinatal HIV prevention aims for elimination. AIDS Read 12: 146, 150.
2. BransonBM, HandsfieldHH, LampeMA, JanssenRS, TaylorAW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55: 1–17.
3. MoodleyD, EsterhuizenTM, PatherT, ChettyV, NgalekaL (2009) High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 23: 1255–1259.
4. Tabu F, Ngonzi J, Mugyenyi G, Bajunirwe F, Mayanja R, et al. (2013) Prevalence of HIV infection among parturients with a negative primary test during the antenatal period at Mbarara Regional Referral Hospital, Uganda [abstract]. SpROGs 2013 Conference; 5–6 Dec 2013; Nottingham, United Kingdom.
5. MoodleyD, EsterhuizenT, ReddyL, MoodleyP, SinghB, et al. (2011) Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis 203: 1231–1234.
6. GrayRH, LiX, KigoziG, SerwaddaD, BrahmbhattH, et al. (2005) Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 366: 1182–1188.
7. DunnDT, NewellML, AdesAE, PeckhamCS (1992) Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340: 585–588.
8. World Health Organization (2012) Global monitoring framework and strategy for the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva: World Health Organization.
9. GreenlandS (1994) Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 140: 290–296.
10. ThompsonSG, HigginsJP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559–1573.
11. Wells G, Shea B, O'Connell D, Peterson J, Welch V, et al. (1999) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa: Ottawa Hospital Research Institute.
12. KimAA, McDougalJS, HargroveJ, RehleT, Pillay-Van WykV, et al. (2010) Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa. AIDS Res Hum Retroviruses 26: 1051–1061.
13. RehleT, ShisanaO, PillayV, ZumaK, PurenA, et al. (2007) National HIV incidence measures—new insights into the South African epidemic. S Afr Med J 97: 194–199.
14. HargroveJW, HumphreyJH, MutasaK, ParekhBS, McDougalJS, et al. (2008) Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22: 511–518.
15. LiangK, GuiX, ZhangYZ, ZhuangK, MeyersK, et al. (2009) A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding. J Infect Dis 200: 682–686.
16. Lu L, Motswere-Chirwa C, Kegwaila K, Matambo S, Kolobe T, et al. (2011) HIV incidence in women during the first postpartum year and implications for prevention of mother-to-child transmission (PMTCT) programs—Francistown, Botswana, 2010 [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 Jul 2011; Rome, Italy.
17. PalasanthiranP, ZieglerJB, StewartGJ, StuckeyM, ArmstrongJA, et al. (1993) Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 167: 441–444.
18. Singh A, Lampe MA, Surendera Babu A, Rao S, Borkowf CB, et al. (2012) HIV seroconversion during prgnancy and mother-to-child HIV transmission: data from the Enhanced Perinatal Surveillance Project, United States, 2005–2010 [abstract]. 19th International AIDS Conference; 22–27 Jul 2012; Washington, District of Columbia, US.
19. ColebundersR, KapitaB, NekweiW, BahweY, LebugheI, et al. (1988) Breastfeeding and transmission of HIV. Lancet 2: 1487.
20. HiraSK, MangrolaUG, MwaleC, ChintuC, TemboG, et al. (1990) Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr 117: 421–424.
21. HumphreyJH, MarindaE, MutasaK, MoultonLH, IliffPJ, et al. (2010) Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ 341: c6580.
22. Van de PerreP, SimononA, MsellatiP, HitimanaDG, VairaD, et al. (1991) Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med 325: 593–598.
23. TovoPA, PalombaE, GabianoC, GalliL, de MartinoM (1991) Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynaecol 98: 940–942.
24. RoongpisuthipongA, SiriwasinW, SimondsRJ, SangtaweesinV, VanpraparN, et al. (2001) HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr 26: 348–351.
25. BirkheadGS, PulverWP, WarrenBL, HackelS, RodriguezD, et al. (2010) Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002–2006. Obstet Gynecol 115: 1247–1255.
26. NesheimS, JamiesonDJ, DannerSP, MaupinR, O'SullivanMJ, et al. (2007) Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. Am J Obstet Gynecol 197: 149.e141–5.
27. Joint United Nations Programme on HIV/AIDS (2012) UNAIDS World AIDS Day Report 2012. Geneva: Joint United Nations Programme on HIV/AIDS.
28. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, et al. (2013) Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003) [abstract]. 20th Conference on Retroviruses and Opportunistic Infections 3–6 Mar 2013; Atlanta, Georgia, US.
29. Abdool KarimQ, Abdool KarimSS, FrohlichJA, GroblerAC, BaxterC, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168–1174.
30. PriceMA, RidaW, MwangomeM, MutuaG, MiddelkoopK, et al. (2012) Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J Acquir Immune Defic Syndr 59: 185–193.
31. KaulR, KimaniJ, NagelkerkeNJ, FonckK, NgugiEN, et al. (2004) Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 291: 2555–2562.
32. CelumC, WaldA, HughesJ, SanchezJ, ReidS, et al. (2008) Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371: 2109–2119.
33. CelumC, WaldA, LingappaJR, MagaretAS, WangRS, et al. (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 427–439.
34. Watson-JonesD, WaldA, CelumC, LingappaJ, WeissHA, et al. (2010) Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol 48: 3496–3503.
35. BaetenJM, DonnellD, NdaseP, MugoNR, CampbellJD, et al. (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367: 399–410.
36. BaetenJM, RichardsonBA, MartinHLJr, NyangePM, LavreysL, et al. (2000) Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr 24: 458–464.
37. FowkeKR, NagelkerkeNJ, KimaniJ, SimonsenJN, AnzalaAO, et al. (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348: 1347–1351.
38. MugoNR, HeffronR, DonnellD, WaldA, WereEO, et al. (2011) Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 25: 1887–1895.
39. WandH, RamjeeG (2011) Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: implications for prevention policy and planning. AIDS Behav 15: 479–486.
40. HeffronR, DonnellD, ReesH, CelumC, MugoN, et al. (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12: 19–26.
41. MorrisonCS, ChenPL, KwokC, RichardsonBA, ChipatoT, et al. (2010) Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 24: 1778–1781.
42. MorrisonCS, WangJ, Van Der PolB, PadianN, SalataRA, et al. (2007) Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS 21: 1027–1034.
43. KeatingMA, HamelaG, MillerWC, MosesA, HoffmanIF, et al. (2012) High HIV incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: implications for the risk of HIV acquisition. PLoS ONE 7: e39109.
44. ClelandJG, AliMM, Capo-ChichiV (1999) Post-partum sexual abstinence in West Africa: implications for AIDS-control and family planning programmes. AIDS 13: 125–131.
45. TahaTE, HooverDR, DallabettaGA, KumwendaNI, MtimavalyeLA, et al. (1998) Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12: 1699–1706.
46. HumphreyJH, HargroveJW, MalabaLC, IliffPJ, MoultonLH, et al. (2006) HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 20: 1437–1446.
47. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach. Geneva: World Health Organization.
48. JohnsonLF, StinsonK, NewellML, BlandRM, MoultrieH, et al. (2012) The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 59: 417–425.
49. BlackV, OsihR, ReesHV, ChersichMF (2009) High HIV incidence or poor test performance? AIDS 23: 2234–2235.
50. LaeyendeckerO, ChurchJD, OliverAE, MwathaA, OwenSM, et al. (2010) Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS ONE 5: e13259.
51. World Health Organization (2011) When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: World Health Organization.
52. DimitrovD, BoilyMC, MarrazzoJ, BeigiR, BrownER (2013) Population-level benefits from providing effective HIV prevention means to pregnant women in high prevalence settings. PLoS ONE 8: e73770.
53. BernasconiD, TavoschiL, RegineV, RaimondoM, GamaD, et al. (2010) Identification of recent HIV infections and of factors associated with virus acquisition among pregnant women in 2004 and 2006 in Swaziland. J Clin Virol 48: 180–183.
54. Boly L, Ndile J, Zwartz F, Sabwa H, Musyoka K, et al. (2011) Screening for HIV seroconversion among pregnant women in rural Namibia [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 Jul 2011; Rome, Italy.
55. KharsanyAB, HancockN, FrohlichJA, HumphriesHR, Abdool KarimSS, et al. (2010) Screening for ‘window-period’ acute HIV infection among pregnant women in rural South Africa. HIV Med 11: 661–665.
56. KiefferMP, NhlabatsiB, MahdiM, HoffmanHJ, KudiaborK, et al. (2011) Improved detection of incident HIV infection and uptake of PMTCT services in labor and delivery in a high HIV prevalence setting. J Acquir Immune Defic Syndr 57: e85–e91.
57. MbizvoMT, KasuleJ, MahomedK, NathooK (2001) HIV-1 seroconversion incidence following pregnancy and delivery among women seronegative at recruitment in Harare, Zimbabwe. Cent Afr J Med 47: 115–118.
58. MunjomaMW, MhlangaFG, MapingureMP, KurewaEN, MashavaveGV, et al. (2010) The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in Zimbabwe. BMC Public Health 10: 668.
59. ReidSE, DaiJY, WangJ, SichalweBN, AkpomiemieG, et al. (2010) Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 53: 606–613.
60. RollinsNC, DedicoatM, DanaviahS, PageT, BishopK, et al. (2002) Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet 360: 389.
61. De Schacht C, Ismael N, Santos I, Calu N, Vubil A, et al. (2011) HIV incidence during pregnancy and post-partum period in Southern Mozambique: impact on vertical HIV transmission [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 Jul 2011; Rome, Italy.
62. GayCL, MwapasaV, MurdochDM, KwiekJJ, FiscusSA, et al. (2010) Acute HIV infection among pregnant women in Malawi. Diagn Microbiol Infect Dis 66: 356–360.
63. BraunsteinSL, IngabireCM, KestelynE, UwizeraAU, MwamarangweL, et al. (2011) High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis 38: 385–394.
64. KinuthiaJ, KiarieJN, FarquharC, RichardsonB, NduatiR, et al. (2010) Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res 8: 510–514.
65. LeroyV, Van de PerreP, LepageP, SabaJ, NsengumuremyiF, et al. (1994) Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988–1992. AIDS 8: 983–986.
66. WawerMJ, SewankamboNK, SerwaddaD, QuinnTC, PaxtonLA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353: 525–535.
67. WoldayD, MelesH, HailuE, MesseleT, MengistuY, et al. (2007) Temporal trends in the incidence of HIV infection in antenatal clinic attendees in Addis Ababa, Ethiopia, 1995–2003. J Intern Med 261: 132–137.
68. Imade G, Sagay S, Musa J, Ocheke A, Adeniyl D, et al. (2012) Declining rates of maternal HIV infection detected at delivery settings in north central Nigeria [abstract]. 19th International AIDS Conference; 22–27 Jul 2012; Washington, District of Columbia, US.
69. Traore CAH, Dielbeogo R, Bagre I, Konate D, Meda N, et al. (2012) Evaluation of HIV incidence during pregnancy in Ouagadougou, Burkina Faso [abstract]. 19th International AIDS Conference; 22–27 Jul 2012; Washington, District of Columbia, US.
70. DuanS, ShenS, BulterysM, JiaY, YangY, et al. (2010) Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health 10: 180.
71. SaphonnV, ParekhBS, DobbsT, MeanC, BunLH, et al. (2005) Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999–2002. J Acquir Immune Defic Syndr 39: 587–592.
72. NesheimS, ParekhB, SullivanK, BulterysM, DobbsT, et al. (2005) Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 21: 537–544.
73. de Freitas OliveiraCA, UedaM, YamashiroR, RodriguesR, SheppardHW, et al. (2005) Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002. J Clin Microbiol 43: 1439–1442.
74. PandoMA, Gomez-CarrilloM, VignolesM, RubioAE, dos Ramos FariasMS, et al. (2011) Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: a Global Fund Project. AIDS Res Hum Retroviruses 27: 17–23.